PLK1 and cancer: To show that FNP1 was able to deliver therapeutically relevant siRNA in vivo, mice with orthotopic tumors were administered FNP1 delivering PLK1 siRNA, previously established to pressure cancer cells into mitotic catastrophe and slow growth in aggressive cancers.[25] Two treatment regimens were investigated (Figure 7D).